Polycystic ovary syndrome (PCOS) is associated with multiple risk factors for cardiovascular diseases, including insulin resistance, diabetes mellitus type 2, obesity, hypertension, and dyslipidaemia. Many studies have assessed the role of adipokines in the etiopathogenesis of PCOS, however, no single biomarker has been recognized to be in causal relation to the syndrome. Apelin has been identified as a new adipokine linked to obesity and insulin resistance. Some studies demonstrated that the apelin / apelin receptor could play a pivotal role in the pathogenesis of polycystic ovary syndrome, however the other yielded controversial results. Underlying mechanisms of possible involvement of apelin/apelin receptor complex are discussed.

1st Department of Internal Medicine Medical Faculty of P J Šafarik University Košice Slovakia

Zobrazit více v PubMed

ABD-EL-AAL DE, MOHAMED SA, AMINE AF, MEKI A-RMA. Vascular endothelial growth factor and insulin-like growth actor-1 in polycystic ovary syndrome and their relation to ovarian blood flow. Eur J Obstet Gynecol Reprod Biol. 2005;118:219–225. https://doi/10.1016/j.ejogrb.2004.07.024 . PubMed DOI

ABD-ELHAFEZ ZZ, MOHAMED MA, ABD-ELMOUTTALEB AT, ABD-ELATIF DM. Evaluation of serum omentin-1 and apelin levels and their association with insulin resistance and obesity in Egyptian women with polycystic ovary syndrome. Int Res J Pharm. 2020;11:32–40. https://doi/10.7897/2230-8407.110216 . DOI

AKINCI B, CELTIK A, TUNALI S, GENC S, YUKSEL F, SECIL M, OZCAN MA, BAYRAKTAR F. Circulating apelin levels are associated with cardiometabolic risk factors in women with previous gestational diabetes. Arch Gynecol Obstet. 2014;289:787–793. https://doi/10.1007/s00404-013-3070-y . PubMed DOI

ALEKSANDROVA K, MOZAFFARIAN D, PISCHON T. Addressing the perfect storm: biomarkers in obesity and pathophysiology o cardiometabolic risk. Clin Chem. 2018;64:142–153. doi: 10.1373/clinchem.2017.275172. PubMed DOI

ALTINKAYA SO, NERGIZ S, KUCUK M, YUKSEL H. Apelin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2014;176:168–172. doi: 10.1016/j.ejogrb.2014.02.022. PubMed DOI

BONGRANI A, MELLOUK N, RAME CH, CORNUAU M, GUÉRIF F, FROMENT P, DUPONT J. Ovarian expression of adipokines in polycystic ovary syndrome: a role for chemerin, omentin, and apelin in follicular growth arrest and ovulatory dysfunction? Int J Mol Sci. 2019;20:1–22. https://doi/10.3390/ijms.20153778 . PubMed DOI PMC

CEKMEZ F, CEKMEZ Y, PIRGON O, CANPOLAT FE, AYDINOZ S, IPCIOGLU OM, KARADEMIR F. Evaluation of new adipocytokines and insulin resistance in adolescents with polycystic ovary syndrome. Eur Cytokine Netw. 2011;22:32–37. https://doi/10.1684/ecn.2011.00.279 . PubMed DOI

CHANG CY, TSAI YC, LEE CH, CHAN TF, WANG SH, SU JH. Lower serum apelin levels in women with polycystic ovary syndrome. Fertil Steril. 2011;95:2520–2523. https://doi/10.1016/fertnstert.2011.04.044 . PubMed DOI

CHOI YS, YANG HI, CHO SH, JUNG JA, JEON YE, KIM HY, SEO SK, LEE BS. Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome. Steroids. 2012;77:1352–1358. doi: 10.1016/j.steroids.2012.08.005. PubMed DOI

DESAI A, PATEL SS. Increased insulin-like growth factor-1 in relation to cardiovascular function in polycystic ovary syndrome: friend or foe? Gynecol Endocrinol. 2015;31:801–807. https://doi/10.3109/09513590.2015.1075497 . PubMed DOI

GOREN K, SAGSOZ N, NOYAN V, YUCEL A, CAGLAYAN O, BOSTANCI MS. Plasma apelin levels in patients with polycystic ovary syndrome. J Turkish-German Gynecol Assoc. 2012;13:27–31. https://doi/10.5152/jtgga.2011.74 . PubMed DOI PMC

HANSEN KA. Polycystic ovary syndrome. S D Med. 2014;67:443. PubMed

HASAN MM, ABD EL HAMMED AA. Serum adipokine (apelin) in lean and obese polycystic ovary syndrome patients before and after metformin treatment. Middle East Fertility Society J. 2018;23:315–318. doi: 10.1016/j.mefs.2018.04.003. DOI

KARBEK B, BOZKURT NC, TOPALOGLU O, ASLAN MS, GUNGUNES A, CAKAL E, DELIBASI T. Relationship of vaspin and apelin levels with insulin resistance and atherosclerosis in metabolic syndrome. Minerva Endocrinol. 2014;39:99–105. PubMed

KARIMI E, MOINI A, YASERI M, SHIRZAD N, SEPIDARKISH M, HOSSEIN-BOROUJERDI M, HOSSEINZADEH-ATTAR MJ. Effects of synbiotic Supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomized double-blind placebo-controlled trial. Brit J Nutrition. 2018;119:398–406. https://doi/10.1017/S0007114517003920 . PubMed DOI

KIM JA, MONTAGNANI M, KOH KK, QUON MJ. Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms. irculation. 2006;113:1888–1904. https://doi/10.1161/CIRCULATIONAHA.105.563213 . PubMed DOI

KRAVARITI M, NAKA KK, KALANTARIDOU SN, KAZAKOS N, KATSOURAS CS, MAKRIGIANNAKIS A, PARASKEVAIDIS EA, CHROUSOS GP, TSATSOULIS A, MICHALIS LK. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90:5088–5095. https://doi/10.1210/jc.2005-0151 . PubMed DOI

KUROWSKA P, BARBE A, ROZYCKA M, CHMIELINSKA J, DUPONT J, RAK A. Apelin in reproductive physiology and pathology of different species: a critical review. Int J Endocrinol. 2018:9170480. doi: 10.1155/2018.9170480. PubMed DOI PMC

LIN K, SUN X, WANG X, WANG H, CHEN X. Circulating adipokine levels in nonobese women with polycystic ovary syndrome and in nonobese control women: a systematic review and meta-analysis. Front Endocrinol. 2021;11 article 537809. https://doi/10.3389/fendo.2020.537809 . PubMed DOI PMC

LIU Q, JIANG J, SHI Y, MO Z, LI M. Apelin/Apelin receptor: A new therapeutic target in Polycystic Ovary Syndrome. Life Sciences. 2020;260:118310. doi: 10.1016/j.lfs.2020.118310. PubMed DOI

Nayaker BS, Thomas S, Ramachandran S, Loganathan S, Sundari M, Mala K. Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination. Epub 2017 Jul 8. PubMed

NAYAKER BS, THOMAS S, RAMACHANDRAN S, LOGANATHAN S, SUNDARI M, MALA K. Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination. Diabetes Metab Syndr. 2017;11(Suppl 2):S841–S851. https://doi/10.1016/j.dsx.2017.07.004 . PubMed DOI

OLSZANECKA-GLINIANOWICZ M, MADEJ P, NYLEC M, OWCZAREK A, SZANECKI W, SKALBA P, CHUDEK J. Circulating apelin level in relation to nutritional status in polycystic ovary syndrome and its association with metabolic and hormonal disturbances. Clin Endocrinol. 2013;79:238–242. https://doi/10.1111/cen.12120 . PubMed DOI

PIYA MK, McTERNAN PG, KUMAR S. Adipokine inflammation and insulin resistance: the role of glucose, lipids, and endotoxin. Journal of Endocrinology. 2013;216:1–15. https://doi/10.1530/JOE-12-0498 . PubMed DOI

POLAK K, CZYZYK A, SIMONCINI T, MECZEKALSKI B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Invest. 2017;40:1–8. https://doi/10.1007/s40618-016-0523-8 . PubMed DOI PMC

ROCHE J, RAMÉ CH, REVERCHON M, MELLOUK N, CORNUAU M, GUERIF F, FROMENT P, DUPONT J. Apelin (APLN) and Apelin Receptor (APLNR) in human ovary: expression, signalling, and regulation of steroidogenesis in primary human luteinized granulosa cells. Biol Reprod. 2016;95:104. https://doi/10.1080/1095/biolreprod.116.141754 . PubMed DOI

SALEH IBRAHIM MK, IBRAHIM MOSTAFA M, MOHAMAD ABDELLA R, ALI MARZOUK S, EL-ATTAR S. Relation of serum apelin levels to ultrasound in images and Doppler index in diagnosed Polycystic ovary syndrome in overweight and obese women. Middle East Fertility Society J. 2018;23:377–383. doi: 10.1016/j.mefs.2018.05.007. DOI

SHIRASUNA K, SHIMIZU T, SAYAMA K, ASAHI T, SASAKI M, BERISHA B, SCHAMS D, MIYAMOTO A. Expression and localization of apelin and its receptor APJ in the bovine corpus luteum during the estrous cycle and prostaglandin F2 alpha-induced luteolysis. Reproduction. 2008;135:519–525. https://doi/10.1530/REP-07-0409 . PubMed DOI

SUIKKARI AM, KOIVISTO VA, RUTANEN EM, YKI-JÄRVINEN H, KARONEN SL, SEPPÄLÄ M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab. 1988;66:266–272. https://doi/10.1210/jcem-66-2-266 . PubMed DOI

SUN X, WU X, ZHOU Y, YU XINYAN, ZHANG W. Evaluation of apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinylestradiol plus Metformin. ed Sci Monit. 2015;21:2547–2552. https://doi/10.12659/MSM.894926 . PubMed DOI PMC

XIE H, LUO G, ZHENG Y, HU D, PENG F, XIE L. Lowered circulating apelin is significantly associated with an increased risk for hypertension: a meta-analysis. Clin Exp Hypertens. 2017;39:435–401. https://doi/10.1080/10641963.2016.1267199 . PubMed DOI